Press releases

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has declared a quarterly dividend of $1.04 per common...

FRANKLIN LAKES, N.J. (July 15, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued a voluntary recall related to certain Alaris™...

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market...

El Paso, Texas (July 14th, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today celebrated the 25th anniversary of BD ChloraPrep™ Skin...